2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Mini-Oral Session

[MO31] Mini-Oral Session 31 Clinical Trial Facilitation Program 1(Trial in Progress)

Sat. Feb 19, 2022 8:20 AM - 9:10 AM Room 3 (Annex 2, 1F, Kyoto International Conference Center)

Chair:Tetsuya Kusumoto(Department of Gastroenterological Surgery / Clinical Research Institute Cancer Research Division),Hideo Baba(Department of Gastroenterological Surgery, Graduate School of Medical Sciences Kumamoto University)

Kiyotaka Yoh1, Melissa Johnson2, Alexander Spira3, Rebecca Heist4, Aaron Lisberg5, Jonathan Greenberg6, Penny Phillips6, Lan Lan6, Wen Gu6, Yong Zhang6, Jacob Sands7 (1.National Cancer Center Hospital East, Kashiwa, Japan, 2.Sarah Cannon Research Institute, Tennessee Oncology, PLLC/OneOncology, Nashville,TN/United States of America, 3.Virginia Cancer Specialists and US Oncology Research, Fairfax, VA/United States of America, 4.Massachusetts General Hospital, Boston, MA/United States of America, 5.University of California Los Angeles, Los Angeles, CA/United States of America, 6.Daiichi Sankyo, Inc., Basking Ridge, NJ/United States of America, 7.Dana-Farber Cancer Institute, Boston, MA/United States of America)

Hidehito Horinouchi1, J.W. Goldman2, F. Moiseenko3, I. Cicin4, E. Filippova5, J. Bar6, P. Tomasini7, C. Ocampo8, D. Sullivan8, D. Maag8, M. Motwani8, J. Jin8, D.R. Camidge9 (1.National Cancer Center Hospital, 2.David Geffen School of Medicine at UCLA, Los Angeles, CA/United States of America, 3.St. Petersburg City Cancer Center, St. Petersburg/Russian Federation, 4.Trakya University Medical Center, Edirne/Turkey, 5.Center of Palliative Medicine De Vita, St. Petersburg/Russian Federation, 6.Sheba Medical Center, Ramat Gan/lsrael, 7.Aix Marseille Univ, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Multidisciplinary Oncology and Therapeutic Innovations Department, Marseille/France, 8.AbbVie, Inc., North Chicago, IL/United States of America, 9.University of Colorado Cancer Center, Aurora, CO/United States of America)

Koichi Goto1, Egbert F. Smit2, Bob T. Li3, Julian Mazieres4, David Planchard5, Kazuhiko Nakagawa6, Luis Paz-Ares7, Silvia Novello8, James Chih-Hsin Yang9, Myung-Ju Ahn10, Geoffrey Liu11, Kenneth O’Byrne12, Mehreteab Aregay13, Ryota Shiga13, Kapil Saxena13, Kaline Pereira13, Gerold Meinhardt13, Pasi A. Janne14 (1.National Cancer Center Hospital East, Kashiwa, Japan, 2.Netherlands Cancer Institute, Amsterdam, Netherlands, 3.Memorial Sloan Kettering Cancer Center, New York, NY, USA, 4.Institut Universitaire du Cancer, Toulouse, France, 5.Gustave Roussy, Villejuif, France, 6.Kindai University Hospital, Osaka, Japan, 7.Hospital Universitario 12 de Octubre, Madrid, Spain, 8.University of Turin, AOU San Luigi-Orbassano (TO), Orbassano, Italy, 9.National Taiwan University Cancer Center, Taipei, Taiwan, 10.Samsung Medical Center, Seoul, South Korea, 11.Princess Margaret Cancer Centre, Toronto, ON, Canada, 12.Princess Alexandra Hospital, Brisbane, QLD, Australia, 13.Daiichi Sankyo, Inc., Basking Ridge, NJ, USA, 14.Dana-Farber Cancer Institute and Belfer Center for Applied Cancer Science, Boston, MA, USA)

Kohei Shitara1, Haeseong Park2, Tanios Bekaii-Saab3, Sunnie S. Kim4, Suneel Kamath5, Michael J. Pishvaian6, Christopher Chen7, David B. Zhen8, Joal Mayor9, Qianwen Tan9, John H. Strickler10 (1.National Cancer Center Hospital East, Kashiwa, Japan, 2.Washington University School of Medicine, 3.Mayo Clinic, 4.University of Colorado Cancer Center, 5.Cleveland Clinic, 6.Johns Hopkins Kimmel Cancer Center, 7.Stanford University School of Medicine, 8.University of Washington, 9.Seagen Inc, 10.Duke University Medical Center)

Hitomi Sakai1, Yoshio Itani2, Yoichi Kobayashi3, Mikiko Sato4, Kazuto Tasaki5, Shoji Nagao6, Masayuki Futagami7, Makoto Yamamoto8, Tetsutaro Hamano9, Nao Suzuki10, Yoshio Yoshida11 (1.Advanced Cancer Translational Institute (ACT), Showa University, 2.Yao Municipal Hospital Palliative Care Center, 3.Department of Obstetrics and Gynecology, Kyorin University, Faculty of Medicine, 4.Department of Obstetrics and Gynecology, Nihon University School of Medicine, 5.Department of Obstetrics and Gynecology, Kurume University School of Medicine, 6.Hyogo Prefectural Cancer Center, 7.Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, 8.Japanese Red Cross Fukui Hospital, 9.P4 Statistics co. ltd., 10.Department of Obstetrics and Gynecology, St. Marianna University School of Medicine Hospital, 11.Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui)

Yoshitaka Zenke1, Keiju Aokage2, Tsuboi Masahiro2, Horinouchi Hidehito3, Nakamura Naoki4, Ishikura Satoshi5, Nishikawa Hiroyoshi6, Kumagai Shogo6, Koyama Shohei6, Kanato Keisuke7, Kataoka Tomoko7, Wakabayashi Masashi7, Sekino Yuta7, Fukutani Miki8, Chen-Yoshikawa Toyofumi9, Okada Morihito10, Takahama Makoto11, Suzuki Kenji12, Ohe Yuichiro3, Watabnabe Shun-Ichi13 (1.Department of Thoracic Oncology, National Cancer Center Hospital East, 2.Division of Thoracic Surgery, National Cancer Center Hospital East, 3.Division of Thoracic Oncology, National Cancer Center Hospital, 4.Department of Radiology, St. Marianna University School of Medicine, 5.Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 6.Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, 7.JCOG Data Center/Operations Office, National Cancer Center Hospital, 8.Clinical Research Support Office, National Cancer Center Hospital East, 9.Department of Thoracic Surgery, Nagoya University School of Medicine, 10.Department of Surgical Oncology, Hiroshima University, 11.Department of General Thoracic Surgery, Osaka City General Hospital, 12.Department of General Thoracic Surgery, Juntendo University School of Medicine, 13.Division of Thoracic Surgery, National Cancer Center Hospital)